Non-members: Click here to review a complimentary excerpt from "Big Data in Pharma: Big Data Function Presence and Valued Data Producers across Medical, Commercial & HEOR Segments"
The 21st century has seen an explosion in the availability of all types of data, including healthcare, social media and transactional information. Together, these and other types of large and complex data sets have come to be known as Big Data. The influence of big data within the pharmaceutical industry is still emerging for organizations facing key medical, commercial, and HEOR decisions.
It is important for biopharmaceutical companies attempting to utilize Big Data in their decision-making to not only understand the most valuable data producers but also the most impactful way to disseminate Big Data analyses. This study presents benchmark data on these questions as well as who are the most frequent internal requestors of Big Data analysis and the presence of a Big Data team or function within benchmark participants. Best Practices, LLC utilized medical, commercial and HEOR segmented responses to investigate these issues. The study offers key benchmarks that will help leaders to better understand the growing influence of Big Data in the biopharmaceutical sector and how it impacts medical, HEOR and commercial operations in the U.S.
This study provides Medical, Commercial and HEOR segmented responses on survey questions.
- Executive Summary
- Big Data Team Overview and Key Study Insights
- Defining Big Data
- Presence of Big Data Team
- Data Producers, Dissemination, and Requestors
SAMPLE KEY METRICS
- Centralized vs decentralized group supporting Big Data projects
- Plans for dedicated Big Data teams
- Impact / value of data producers
- Impact of data dissemination channels
- Target audiences for data analysis
- Frequency of data requests by source
SAMPLE KEY FINDING
- Majority of Each Segment Rate Internal Groups as Most Impactful Targets for Data Analysis: Internal Commercial, Medical and Development functions were rated by a majority of medical, commercial and HEOR respondents as the most impactful targets for data analysis presentations. A majority of each segment also said these internal groups were also the most frequent requestors of presentations.
Best Practices, LLC engaged 22 leaders from 18 pharmaceutical companies through a benchmarking survey. Research analysts also conducted seven deep-dive executive interviews with selected benchmark participants.